IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Market Cap	17.96B
Revenue (ttm)	20.55B
Net Income (ttm)	972.70M
Shares Out	n/a
EPS (ttm)	3.32
PE Ratio	18.47
Forward PE	n/a
Dividend	0.80 (1.30%)
Ex-Dividend Date	Feb 18, 2025

Volume	849,269
Average Volume	1,403,551
Open	61.75
Previous Close	61.15
Day's Range	61.50 - 64.21
52-Week Range	58.65 - 107.54
Beta	1.07
RSI	37.90
Earnings Date	May 26, 2025

About NSE:IOLCP

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 2,777
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: IOLCP

Financial Performance

In 2023, NSE:IOLCP's revenue was 21.33 billion, a decrease of -3.80% compared to the previous year's 22.17 billion. Earnings were 1.34 billion, a decrease of -3.39%.